BPaL(M) Regimen for the Treatment of MDR/RR-TB

Clinical trial NCT05381194 · RECRUITING

Trial details

NCT number: NCT05381194
Sponsor: Asan Medical Center
Status: RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Multidrug- and Rifampicin-resistant Tuberculosis

Start date: 2022-12-13
Primary completion: 2027-12-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.